论文部分内容阅读
Modeling SDLT2 Inhibition,a Novel Approach to the Treatment of Type 2 Diabetes
【机 构】
:
Bristol-Myers Squibb Company
【出 处】
:
第二届“定量药理与新药评价”国际学术会议
【发表日期】
:
2010年期
其他文献
AIM: To develop rapid assay colloid gold immunochromatography strip for abrin determination, which could be used as technique references for clinical diagno
会议
Mechanism-based inhibition of CYP1A2 involved in fluoroquinolone-theophylline interaction:Applicatio
会议
Differential expression of non-coding RNA after traumatic spinal cord injury (TSCI) is closely related to the pathophysiological process. The purposes of this s
Adenovirus (Ad) vector has the capacity to efficiently transduce a wide variety of cell types and tissues regardless of the mitotic status of the cell, and
会议
AIM:To study the pharmacokinetics of abrin P2 in mice, as the basis for developing new anti-cancer drug.METHODS: 125I-abrin P2 was administered orally 43.8
会议